(Interview) BrainsWay Aims to Treat COVID-Caused Depression by “Jumpstarting” Brain
In the media » (Interview) BrainsWay Aims to Treat COVID-Caused Depression by “Jumpstarting” Brain
BrainsWay CEO Christopher von Jako discusses how Deep TMS is used to treat neurological conditions such as depression and obsessive-compulsive disorder exacerbated by the coronavirus (Covid-19) pandemic.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
